Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Chemotherapy with Celecoxib and Bisphosphonates in Metastatic Breast Cancer
NCT01067989Phase 2Terminated
- Sponsor
- Emek Medical Center
- Start
- Mar 2010
- Primary completion
- Apr 2014
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, capecitabine, methotrexate, celecoxib, pamidronate in breast cancer, sponsored by Emek Medical Center. Started Mar 2010; status: terminated.
02
Drugs
cyclophosphamidecapecitabinemethotrexatecelecoxibpamidronate
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01067989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01067989.